StonvexLoading…
StonvexCore line items from PSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $132.38B | $143.15B | $147.40B | $169.99B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $4.40B | $2.12B | $7.01B | $11.02B |
EPS (Diluted) | $10.79 | $4.99 | $15.48 | $23.27 |
Total Assets | $73.68B | $72.58B | $75.50B | $76.44B |
Total Liabilities | $43.44B | $44.12B | $43.85B | $42.34B |
Cash & Equivalents | $1.12B | $1.74B | $3.32B | $6.13B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 408.05M | 421.89M | 453.21M | 473.73M |